SENSEX
NIFTY
GOLD
USD/INR

Weather

image 30    C

Economy News

The Economic Times

Economy / The Economic Times

details

Dr. Reddy's launches nivolumab biosimilar in India

Dr Reddy's Laboratories has taken a significant step in cancer care with the introduction of NIVORZ, a biosimilar of nivolumab. Designed to enhance immune response against a variety of cancers, this new treatment has received approval from the DCGI for twelve specific indications. By making this intravenous therapy available, Dr Reddy's aims to broaden access to affordable, high-quality cancer care options for patients in need.

15 Sep 2026 7:35 pm